Table of contents: 1)<Tab/>Introduction. 2)<Tab/>Pharmaceutical sector in general, main arguments put forward by the companies and counter-arguments. 3)<Tab/>GlaxoSmithKlein's CSR claims and counter-evidence: i)<Tab/>Medicines for the developing world. ii)<Tab/>Business ethics and integrity. iii)<Tab/>Environment, health and safety. iv)<Tab/>Research …
showed first 75 words of 4600 total

showed last 75 words of 4600 total
…based company of burying unfavourable results. The lawsuit, launched by New York State's attorney general Eliot Spitzer, accused GSK of "repeated and persistent fraud," alleging that the company suppressed data from at least four trials of the antidepressant paroxetine (marketed as Seroxat in Britain and as Paxil in the United States) (12 June, p 1395). The trials, which studied the drugs in adolescents, either showed no benefit over placebo or a slight increase in self harming behaviour.